Date Filed | Type | Description |
01/24/2023 |
4
| O'Brien Ronan (GC, CCO & Secretary) has filed a Form 4 on Pear Therapeutics, Inc.
Txns:
| Sold 12,162 shares
@ $1.13, valued at
$13.7k
|
|
01/24/2023 |
4
| Snow Ellen (Chief Accounting Officer) has filed a Form 4 on Pear Therapeutics, Inc.
Txns:
| Sold 8,027 shares
@ $1.13, valued at
$9.1k
|
|
01/24/2023 |
4
| Strandberg Julia (Chief Commercial Officer) has filed a Form 4 on Pear Therapeutics, Inc.
Txns:
| Sold 12,688 shares
@ $1.13, valued at
$14.3k
|
|
01/24/2023 |
4
| Brenner Erin K. (Chief Product Dev. Officer) has filed a Form 4 on Pear Therapeutics, Inc.
Txns:
| Sold 8,690 shares
@ $1.13, valued at
$9.8k
|
|
01/24/2023 |
4
| GUIFFRE CHRISTOPHERD T (CFO, COO, Treas., & Asst. Sec.) has filed a Form 4 on Pear Therapeutics, Inc.
Txns:
| Sold 19,540 shares
@ $1.13, valued at
$22.1k
|
|
01/24/2023 |
4
| Jeffery Katherine (Chief People Officer) has filed a Form 4 on Pear Therapeutics, Inc.
Txns:
| Sold 7,096 shares
@ $1.13, valued at
$8k
|
|
01/24/2023 |
4
| Maricich Yuri (Chief Medical Officer) has filed a Form 4 on Pear Therapeutics, Inc.
Txns:
| Sold 12,162 shares
@ $1.13, valued at
$13.7k
|
|
01/24/2023 |
4
| McCann Corey (President and CEO) has filed a Form 4 on Pear Therapeutics, Inc.
Txns:
| Sold 34,731 shares
@ $1.13, valued at
$39.2k
|
|
01/18/2023 |
4
| Brenner Erin K. (Chief Product Dev. Officer) has filed a Form 4 on Pear Therapeutics, Inc.
Txns:
| Exercised 22,000 restricted stock units
@ $0 |
|
01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/13/2022 |
4
| LJ10 LLC (10% Owner) has filed a Form 4 on Pear Therapeutics, Inc.
Txns:
| Disposed of 430,000 shares
@ $0 |
|
12/09/2022 |
4
| Brenner Erin K. (Chief Product Dev. Officer) has filed a Form 4 on Pear Therapeutics, Inc.
Txns:
| Exercised 15,000 options to buy
@ $1, valued at
$15k
|
|
11/15/2022 |
4
| 5AM Partners IV, LLC (10% Owner) has filed a Form 4 on Pear Therapeutics, Inc.
Txns:
| Sold 28,205 shares
@ $3.19, valued at
$90k
Sold 1,175 shares
@ $3.19, valued at
$3.7k
Sold 11,643 shares
@ $2.79, valued at
$32.5k
Sold 485 shares
@ $2.79, valued at
$1.4k
Sold 61,222 shares
@ $2.52, valued at
$154.3k
Sold 2,551 shares
@ $2.52, valued at
$6.4k
|
|
11/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/16/2022 |
4
| 5AM Partners IV, LLC (10% Owner) has filed a Form 4 on Pear Therapeutics, Inc.
Txns:
| Sold 273,664 shares
@ $1.94, valued at
$530.9k
Sold 11,403 shares
@ $1.94, valued at
$22.1k
Sold 261,840 shares
@ $1.81, valued at
$473.9k
Sold 10,910 shares
@ $1.81, valued at
$19.7k
Sold 337 shares
@ $1.75, valued at
$589.8 Sold 14 shares
@ $1.75, valued at
$24.5 |
|
09/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/16/2022 |
4
| Reddy Kirthiga (Director) has filed a Form 4 on Pear Therapeutics, Inc.
Txns:
| Granted 100,000 restricted stock units
@ $0 |
|
06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/16/2022 |
4
| Rajaraman Shivakumar (Director) has filed a Form 4 on Pear Therapeutics, Inc.
Txns:
| Granted 100,000 restricted stock units
@ $0 |
|
06/16/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
06/16/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
06/16/2022 |
3
| Rajaraman Shivakumar (Director) has filed a Form 3 on Pear Therapeutics, Inc. |
05/27/2022 |
4
| Brenner Erin K. (Chief Product Dev. Officer) has filed a Form 4 on Pear Therapeutics, Inc.
Txns:
| Exercised 15,000 options to buy
@ $1, valued at
$15k
|
|
02/18/2022 |
4
| O'Brien Ronan (CCO, GC, & Secretary) has filed a Form 4 on Pear Therapeutics, Inc.
Txns:
| Granted 73,528 options to buy
@ $4.06, valued at
$298.5k
Granted 93,333 restricted stock units
@ $0 |
|
|